Trendlines Group, Ltd. (OTC: TRNLY) (Singapore: 42T), interview with co-CEO/Chairman Steve Rhodes, discussing the company's investment strategy in early-stage medical and agricultural innovation companies in Israel and Singapore. Since 2011, Trendlines' successful strategy, of hands-on investment has yielded over a 10X return, and a 95% IRR on 8 exits to date.
The company currently has 51 companies in it's portfolio with a carry value of about $100 million. (This may be a conservative estimate as it's exits have yielded returns which were 3 . . .
This content is available to members only.
If you are an existing member, please LOGIN
Note a member? Sign up for a FREE trial account ($195 per month value), and get immediate access. Free offer expires May 29, 2019.
Register New Account
Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2